Myeloma Trials
















S1304: Phase II Study comparing two doses of Kyprolis with decadron for relapsed/refractory Myeloma

Connect MM Multiple Myeloma Disease Registry

ECOG E1A11:   Randomized Phase III Trial of Bortezomib, LENalidomide and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide and Dexamethasone (CRd) Followed by Limited or Indefinite DURation Lenalidomide MaintenANCE in Patients with Newly Diagnosed Symptomatic Multiple Myeloma (ENDURANCE)